# Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute

> **NCT01938417** · — · COMPLETED · sponsor: **University of Lausanne Hospitals** · enrollment: 12 (actual)

## Conditions studied

- Orthopedic Operations

## Interventions

- **DRUG:** tobramycin

## Key facts

- **NCT ID:** NCT01938417
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938417, "Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01938417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*